Data updated: Mar 10, 2026
CARBIDOPA AND LEVODOPA
CARBIDOPA
Approved 1992-08-28
24
Indications
--
Phase 3 Trials
33
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1992-08-28
- Routes
- ORAL
- Dosage Forms
- TABLET, EXTENDED RELEASE, TABLET, TABLET, ORALLY DISINTEGRATING, CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPA Approval History
Loading approval history...
What CARBIDOPA AND LEVODOPA Treats
24 FDA approvalsOriginally approved for its first indication in 1992 . Covers 24 distinct patient populations.
- Other (24)
Other
(24 approvals)- • Approved indication (Aug 1992)
- • Approved indication (Sep 1993)
- • Approved indication (Mar 1994)
- • Approved indication (Jun 1995)
- • Approved indication (Sep 1999)Label Letter
- • Approved indication (May 2004)
- • Approved indication (Jun 2004)
- • Approved indication (Jun 2004)
- • Approved indication (Aug 2007)
- • Approved indication (Jun 2008)
- • Approved indication (Sep 2008)
- • Approved indication (Oct 2008)
- • Approved indication (Jul 2009)
- • Approved indication (Sep 2009)
- • Approved indication (Jun 2010)
- • Approved indication (Feb 2013)
- • Approved indication (Jun 2019)
- • Approved indication (May 2021)
- • Approved indication (Oct 2021)
- • Approved indication (Sep 2022)
- • Approved indication (Nov 2022)
- • Approved indication (Apr 2023)
- • Approved indication (Jun 2024)
- • Approved indication (Jan 2025)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CARBIDOPA AND LEVODOPA FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.